๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer

โœ Scribed by Martoni, Andrea; Pacciarini, Maria Adele; Pannuti, Franco

Book ID
122553629
Publisher
Elsevier Science
Year
1985
Weight
380 KB
Volume
21
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II study of oral idarubicin (4-d
A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer
โœ Nicholas S. A. Stuart; Michael H. Cullen; Terrence J. Priestman; George R. P. Bl ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 352 KB

Idarubicin (4-demethoxydaunorubicin: DMDNR) is an orally active analogue of daunorubicin that has shown promising activity in animal and early clinical studies. We gave idarubicin in a phase II study to patients with advanced breast cancer unresponsive to hormonal manipulation and in some cases to s

Phase II clinical and pharmacological st
Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer
โœ Robert Milroy; Jeffrey Cummings; Stanley B. Kaye; Stephen W. Banham ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 298 KB

4-Demethoxydaunorubicin (4-DMDNR) is an oral anthracycline with antitumour activity demonstrated in a number of clinical studies. We have assessed the usefulness of 4-DMDNR in 16 patients with advanced small cell lung cancer, none of whom had received previous chemotherapy. There were no complete or